Symbiotec Pharmalab Ltd.

₹1133.55

- 4.50 (-0.40%)

04:01 pm - close price

BSE: SYMBIOTEC

NSE: SYMBIOTEC

Industry: Pharmaceuticals & Drugs

House: Private

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 17.52Good: 5

✅

Adjusted EPS

Bad: 3Current: 17.52Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 12.41Good: 20

🟡

Current Ratio

Bad: 1Current: 0.92Good: 2

❌

Return On Equity (ROE)

Bad: 5Current: 11.22Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 21.78Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 17.52Good: 5

✅

Adjusted EPS

Bad: 3Current: 17.52Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 12.41Good: 20

🟡

Current Ratio

Bad: 1Current: 0.92Good: 2

❌

Return On Equity (ROE)

Bad: 5Current: 11.22Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 21.78Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	6817.97	5665.14	7162.47	7515.54	8691.49
Operational Expenses+	5503.56	4969.72	5441.99	5488.36	6304.79
Operating Profit	1314.41	695.42	1720.48	2027.18	2386.70
Other Income	29.95	64.59	70.87	44.25	31.09
OPM %	19.28	12.28	24.02	26.97	27.46
Depreciation and Amortisation	258.28	285.22	388.22	431.01	532.83
Interest	31.42	81.36	79.64	169.12	261.40
Profit Before Tax	1054.66	382.68	1309.83	1469.75	1533.63
Tax	281.79	147.18	311.35	495.91	432.64
Net Profit	775.27	234.86	1000.55	967.85	1099.03

Balance Sheet

In Rs. Cr.	202003	202103	202203	202303	202403	202503	202603
Assets+	-	-	8151.76	9899.88	12947.85	15796.51	17807.92
Liabilities+	0.00	0.00	8151.76	9899.88	12947.85	15796.51	17807.92

Cash Flow Statement

In Rs. Cr.	202003	202103	202203	202303	202403	202503	202603
Cash from Operating Activity+	-	-	177.11	692.38	1875.02	472.56	1745.93
Cash from Investing Activity	-	-	-316.44	-2199.90	-2064.06	-3065.24	-2269.30
Cash from Financing Activity	-	-	151.40	1461.42	218.48	2781.63	359.87
Net Cash Flow	-	-	12.07	-46.10	29.44	188.95	-163.50
Opening Cash & Cash Equivalents	-	-	79.55	91.61	45.51	74.95	263.90
Closing Cash & Cash Equivalents	-	-	91.62	45.51	74.95	263.90	100.40

Shareholder Pattern

In %	AUG'26	JUN'26
Promoters+	33.28	0.00
Public+	66.72	0.00
Custodians	0.00	0.00
Number of Shareholders	427730	0

Corporate Actions

9 events in the last 3 years

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Cash Flow Statement

In Rs. Cr.	202003	202103	202203	202303	202403	202503	202603
Cash from Operating Activity+	-	-	177.11	692.38	1875.02	472.56	1745.93
Cash from Investing Activity	-	-	-316.44	-2199.90	-2064.06	-3065.24	-2269.30
Cash from Financing Activity	-	-	151.40	1461.42	218.48	2781.63	359.87
Net Cash Flow	-	-	12.07	-46.10	29.44	188.95	-163.50
Opening Cash & Cash Equivalents	-	-	79.55	91.61	45.51	74.95	263.90
Closing Cash & Cash Equivalents	-	-	91.62	45.51	74.95	263.90	100.40

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	6817.97	5665.14	7162.47	7515.54	8691.49
Operational Expenses+	5503.56	4969.72	5441.99	5488.36	6304.79
Operating Profit	1314.41	695.42	1720.48	2027.18	2386.70
Other Income	29.95	64.59	70.87	44.25	31.09
OPM %	19.28	12.28	24.02	26.97	27.46
Depreciation and Amortisation	258.28	285.22	388.22	431.01	532.83
Interest	31.42	81.36	79.64	169.12	261.40
Profit Before Tax	1054.66	382.68	1309.83	1469.75	1533.63
Tax	281.79	147.18	311.35	495.91	432.64
Net Profit	775.27	234.86	1000.55	967.85	1099.03

Shareholder Pattern

In %	AUG'26	JUN'26
Promoters+	33.28	0.00
Public+	66.72	0.00
Custodians	0.00	0.00
Number of Shareholders	427730	0

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Balance Sheet

In Rs. Cr.	202003	202103	202203	202303	202403	202503	202603
Assets+	-	-	8151.76	9899.88	12947.85	15796.51	17807.92
Liabilities+	0.00	0.00	8151.76	9899.88	12947.85	15796.51	17807.92

Ratios

Reported EPS

Bad: 2Current: 17.52Good: 5

✅

Adjusted EPS

Bad: 3Current: 17.52Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 12.41Good: 20

🟡

Current Ratio

Bad: 1Current: 0.92Good: 2

❌

Return On Equity (ROE)

Bad: 5Current: 11.22Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 21.78Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 17.52Good: 5

✅

Adjusted EPS

Bad: 3Current: 17.52Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 12.41Good: 20

🟡

Current Ratio

Bad: 1Current: 0.92Good: 2

❌

Return On Equity (ROE)

Bad: 5Current: 11.22Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 21.78Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Symbiotec Pharmalab Ltd.

₹1133.55

- 4.50 (-0.40%)

04:01 pm - close price

BSE: SYMBIOTEC

NSE: SYMBIOTEC

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Corporate Actions

9 events in the last 3 years